Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Skin Tumor”

1,240 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,240 results

Early research (Phase 1)Study completedNCT03229278
What this trial is testing

Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma

Who this might be right for
LymphomaMetastatic Malignant Solid NeoplasmMetastatic Melanoma+26 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Study completedNCT00026143
What this trial is testing

Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma

Who this might be right for
Recurrent MelanomaStage IV Melanoma
National Cancer Institute (NCI) 60
Not applicableUnknownNCT06115655
What this trial is testing

A Single-center, Prospective Cohort Study on the Differentiation of Benign and Malignant Bile Duct Stenosis Based on Bile and Peripheral Blood cfDNA Methylation Profiles

Who this might be right for
Bile Duct NeoplasmsJaundice, ObstructiveBile Duct Diseases
Air Force Military Medical University, China 161
Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Not applicableStudy completedNCT01990248
What this trial is testing

An Observational Safety Study in Zelboraf (Vemurafenib)-Treated Patients With BRAF-V600 Mutation-Positive Unresectable or Metastatic Melanoma (ZeSS)

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 339
Early research (Phase 1)Study completedNCT01149343
What this trial is testing

Evaluation of a New Vaccine Treatment for Patients With Metastatic Skin Cancer

Who this might be right for
Melanoma
GlaxoSmithKline 107
Testing effectiveness (Phase 2)Study completedNCT02187991
What this trial is testing

Study to Compare Alisertib With Paclitaxel vs. Paclitaxel Alone in Metastatic or Locally Recurrent Breast Cancer

Who this might be right for
Breast CancerBreast CarcinomaBreast Tumors+1 more
US Oncology Research 169
Not applicableLooking for participantsNCT07250204
What this trial is testing

A Study on Combined Low-pass Whole-genome and Methylome Testing of Bloody Nipple Discharge Specimens for Benign-Malignant Differentiation.

Who this might be right for
Breast CancerNipple Discharge
Hubei Cancer Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT04924413
What this trial is testing

L-TIL Plus Tislelizumab as First-line Treatment in Advanced Malignant Melanoma

Who this might be right for
Malignant Melanoma
Quanli Gao 9
Not applicableStudy completedNCT05395013
What this trial is testing

Efficacy and Safety of Plastic, Covered and Uncovered Self-expandable Metal Stents in the Treatment of Malignant Biliary Obstructions (NEOSTENT)

Who this might be right for
Common Bile Duct StrictureJaundice; Malignant
Azienda Unità Sanitaria Locale della Romagna 3,149
Not applicableStudy completedNCT02612168
What this trial is testing

Melanoma Image Analysis Algorithm (MIAA) Validation Study

Who this might be right for
Malignant Melanoma
Skin Analytics Limited 514
Not applicableEnded earlyNCT00899132
What this trial is testing

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Who this might be right for
Non-melanomatous Skin CancerPancreatic CancerSmall Intestine Cancer+1 more
Case Comprehensive Cancer Center 180
Testing effectiveness (Phase 2)Ended earlyNCT02050321
What this trial is testing

A Phase II Study of Vemurafenib Combined With Acitretin in Patients With Advanced Melanoma

Who this might be right for
Malignant Melanoma
University of Arizona 2
Not applicableStudy completedNCT01641068
What this trial is testing

Memory and Thinking Skills Workshop to Improve Cognition in Gynecologic and Breast Cancer Survivors With Cognitive Symptoms

Who this might be right for
Breast CarcinomaCancer SurvivorCognitive Side Effects of Cancer Therapy+1 more
University of Washington 20
Not applicableUnknownNCT04353050
What this trial is testing

Atypical MOLes and Melanoma Early Detection Study (MoleMed)

Who this might be right for
MelanomaMelanoma (Skin)Moles+9 more
Russian Academy of Medical Sciences 350
Testing effectiveness (Phase 2)Ended earlyNCT03391050
What this trial is testing

APR-246 in Combination With Dabrafenib in Resistant Patients With BRAF V600 Mutant Melanoma

Who this might be right for
Melanoma
Aprea Therapeutics 3
Early research (Phase 1)Study completedNCT00004016
What this trial is testing

Interferon Gamma in Treating Patients With Recurrent or Metastatic Melanoma or Other Solid Tumors

Who this might be right for
Melanoma (Skin)Unspecified Adult Solid Tumor, Protocol Specific
University of Rochester
Early research (Phase 1)Active Not RecruitingNCT02159495
What this trial is testing

Genetically Modified T-cell Immunotherapy in Treating Patients With Relapsed/Refractory Acute Myeloid Leukemia and Persistent/Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm

Who this might be right for
Adult Acute Myeloid Leukemia in RemissionAcute Biphenotypic LeukemiaEarly Relapse of Acute Myeloid Leukemia+10 more
City of Hope Medical Center 31
Testing effectiveness (Phase 2)Study completedNCT01248936
What this trial is testing

RO5185426 in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Hoffmann-La Roche 374
Testing effectiveness (Phase 2)Study completedNCT02537600
What this trial is testing

Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis

Who this might be right for
Malignant Melanoma
Center Eugene Marquis 43
Next Page